Boldly transforming the lives of individuals with rare neurological diseases
Science-driven and patient-focused, our mission is to bring treatments to individuals with rare neurological diseases who have little or no treatment options.
Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for rare neurological diseases.
At Ovid, we seek to understand what matters most to individuals with rare diseases and their families. We are committed to address the challenges they face every day.
- Ovid Therapeutics to Host Educational Webinar on Angelman Syndrome and OV101 Development Program
- Ovid Therapeutics to Present at the Child Neurology Society/International Child Neurology Association (CNS/ICNA) Virtual Congress
- Ovid Therapeutics Provides Soticlestat (OV935/TAK-935) Results from ARCADE and ENDYMION Studies Showing Seizure Reduction in Rare Epilepsies
- Ovid Therapeutics to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference